Trial Site Detail

 

Drug:
BIIB022
Trial:
Phase 1 Study of BIIB022 (Anti-IGF-1R Monoclonal Antibody) in Relapsed/Refractory Solid Tumors
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

Site name unknown, Los Angeles, CA

     
Los Angeles , CA
USA

 

Principal Investigator:
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
Site name unknown, Los Angeles, CA Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.